Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (OTCBB - OTCQB:SNGX)

0.622
Delayed Data
As of 3:42pm ET
 -0.048 / -7.16%
Today’s Change
0.44
Today|||52-Week Range
2.48
-44.96%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close0.67
Today’s open0.68
Day’s range0.62 - 0.69
Volume172,435
Average volume (3 months)76,390
Market cap$21.1M
Dividend yield--
Data as of 3:42pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)+30.23%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+24.50%
P/E ratioNM
Price/Sales3.36
Price/Book--

Competitors

 Today’s
change
Today’s
% change
XTNTXtant Medical Holdin...+0.10+5.48%
CSBRChampions Oncology I...+0.04+1.82%
GENEGenetic Technologies...+0.03+1.48%
ROSGRosetta Genomics Ltd+0.01+0.90%
Data as of 4:00pm ET, 06/29/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$8.8M
Annual profit (last year)-$7.8M
Net profit margin-89.31%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer &
Senior Vice President
Karen R. Krumeich
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers

Search for Jobs